Generics and Specialty Formulation

Lyrus has more than 60 products and 150 SKUs registered in Africa and has started registering its products in Asian markets however the major focus markets to remain are Regulated Markets in Europe, Australia, Canada, US and South Africa.

Lyrus’s current and future formulation portfolio comprises of ethical (branded and generics), OTC and Nutraceuticals in all conventional as well as novel dosage forms.

Formulation Development

Generics and Specialty Formulation

Lyrus has more than 60 products and 150 SKUs registered in Africa and has started registering its products in Asian markets however the major focus markets to remain are Regulated Markets in Europe, Australia, Canada, US and South Africa.